We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Serono and Flamel to Collaborate on Extended Release Formulation
Merck Serono and Flamel to Collaborate on Extended Release Formulation
December 20, 2007
Flamel Technologies announced that it has entered into a collaboration with Merck Serono, a division of Merck KGaA, to investigate the applicability of Flamel’s Medusa technology for the extended release of a therapeutic protein of Merck Serono’s portfolio. Business Wire
